水飛薊 Milk Thistle × 非酒精性脂肪肝
The evidence base for silymarin in NAFLD/MASLD is split between a consistent surrogate-marker signal and a failed hard-endpoint record.
The evidence base for silymarin in NAFLD/MASLD is split between a consistent surrogate-marker signal and a failed hard-endpoint record. Multiple meta-analyses (n=587 to n=2375 across 8-26 RCTs) consistently show statistically significant reductions in ALT and AST and some improvement in ultrasound-based steatosis indices, which is why Examine assigns a B grade for the Liver Enzymes outcome. However, liver enzymes are a surrogate biomarker, and the two best-designed biopsy-endpoint RCTs both failed their primary histologic endpoints: the NCCIH-funded multicenter SyNCH trial (n=78, p=0.79) and the Kuala Lumpur RCT (n=99, p=0.467). The AASLD MASLD Practice Guidance explicitly states silymarin 'did not improve NASH histology' and does not recommend it, and all six NAFLD secondary outcomes in Examine (BMI, lipids, insulin resistance) graded D / no effect. Weighing a robust but surrogate-only benefit against a negative histology record and an explicit guideline non-recommendation, grade C (evidence exists but small/inconsistent/uncertain on the outcome that matters) is the honest call rather than Examine's B.
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.421
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
台灣社群（PTT Health/regimen/Pharmacy/WomenTalk）對水飛薊護肝討論量中等且持續至 2026 年，但極少直接以「非酒精性脂肪肝」為框架分享第一手實測，多停在「應酬、熬夜、護肝」一般用途。反應分歧：部分鄉民與藥師認為它是相對有效且便宜的保肝成分（『自己吃了覺得很有效果』『副作用少得驚人』『健保給付的保肝產品』），但同樣有專業者與懷疑派強調 NAFLD 核心是飲食控制與運動減重，並提出『降 GOT/GPT 不等於保肝』、動物急性肝損模型無法外推到人類慢性脂肪肝等質疑。對 NAFLD 本身的『逆轉』功效並無社群共識。整體第一手脂肪肝實測數據稀少；網路上充斥大量 Dcard/PTT『護肝排行榜』導購文（gotokeyword、ATG、mybest、gankong 等 SEO/affiliate 站），業配污染偏高。
分歧／無共識（多數心得針對應酬熬夜的一般護肝，而非非酒精性脂肪肝；針對 NAFLD 逆轉的第一手實測幾乎空白，正面經驗與『沒效、要靠減重運動』的懷疑並存）
- 個人過敏反應（提醒服用前留意體質）
依論壇被提及頻率，非銷售或品質排序。
- NOW Foods（諾奧）水飛薊膠囊
- GNC 水飛薊
- 佳護 水飛薊
- 斯斯保肝（含 silymarin）
- 永信 肝福膠囊
- 好市多（Costco）含水飛薊保健品
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 減重（飲食調整與運動）
- 地中海飲食型態
- 減少或戒除酒精
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-nafld-INT-milk-thistle-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "水飛薊能改善非酒精性脂肪肝",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}